High Tower Advisors, LLC Dexcom Inc Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 87,108 shares of DXCM stock, worth $7.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

87,108

Previous 68,663 26.86%

Holding current value

$7.02 Million

Previous $7.79 Million 25.02%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $1.18 Million - $2.14 Million	18,445 Added 26.86%	87,108 $5.84 Million
Q2 2024 Aug 13, 2024	SELL	$110.31 - $140.45 $2.59 Million - $3.3 Million	-23,505 Reduced 25.5%	68,663 $7.79 Million
Q1 2024 May 06, 2024	BUY	$114.22 - $140.1 $3.79 Million - $4.65 Million	33,176 Added 56.24%	92,168 $12.8 Million
Q4 2023 Feb 12, 2024	SELL	$75.49 - $124.16 $1.2 Million - $1.97 Million	-15,836 Reduced 21.16%	58,992 $7.32 Million
Q3 2023 Nov 08, 2023	BUY	$86.06 - $137.93 $927,726 - $1.49 Million	10,780 Added 16.83%	74,828 $6.98 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $477,210 - $555,748	4,243 Added 7.09%	64,048 $8.23 Million
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $149,448 - $176,636	1,437 Added 2.46%	59,805 $6.95 Million
Q4 2022 Feb 08, 2023	SELL	$84.98 - $122.67 $522,796 - $754,665	-6,152 Reduced 9.54%	58,368 $6.61 Million
Q3 2022 Nov 09, 2022	SELL	$76.35 - $94.18 $463,749 - $572,049	-6,074 Reduced 8.6%	64,520 $5.2 Million
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $3.4 Million - $6.65 Million	50,016 Added 243.06%	70,594 $5.26 Million
Q1 2022 May 12, 2022	SELL	$94.08 - $130.2 $256,932 - $355,576	-2,731 Reduced 11.72%	20,578 $10.6 Million
Q4 2021 Feb 10, 2022	BUY	$129.87 - $162.82 $720,778 - $903,651	5,550 Added 31.25%	23,309 $12.6 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $660,108 - $885,711	-6,186 Reduced 25.83%	17,759 $9.73 Million
Q2 2021 Aug 06, 2021	SELL	$80.99 - $107.93 $325,903 - $434,310	-4,024 Reduced 14.39%	23,945 $10.2 Million
Q1 2021 May 10, 2021	SELL	$84.79 - $104.74 $1.87 Million - $2.31 Million	-22,071 Reduced 44.11%	27,969 $10.1 Million
Q4 2020 Feb 10, 2021	BUY	$78.0 - $104.5 $1.65 Million - $2.21 Million	21,159 Added 73.26%	50,040 $18.5 Million
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $1.2 Million - $1.42 Million	-12,561 Reduced 30.31%	28,881 $11.9 Million
Q2 2020 Aug 10, 2020	SELL	$62.68 - $105.34 $544,187 - $914,561	-8,682 Reduced 17.32%	41,442 $16.8 Million
Q1 2020 May 21, 2020	SELL	$47.79 - $75.63 $491,998 - $778,610	-10,295 Reduced 17.04%	50,124 $13.5 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $495,541 - $775,248	-13,532 Reduced 18.3%	60,419 $13.2 Million
Q3 2019 Nov 12, 2019	BUY	$35.53 - $43.8 $1.17 Million - $1.44 Million	32,901 Added 80.15%	73,951 $11 Million
Q2 2019 Aug 13, 2019	BUY	$27.84 - $38.92 $261,139 - $365,069	9,380 Added 29.62%	41,050 $6.15 Million
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $804,991 - $1.09 Million	-28,678 Reduced 47.52%	31,670 $3.78 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $156,542 - $216,745	5,800 Added 10.63%	60,348 $7.24 Million
Q3 2018 Nov 09, 2018	SELL	$23.35 - $36.72 $330,612 - $519,918	-14,159 Reduced 20.61%	54,548 $7.84 Million
Q2 2018 Aug 14, 2018	SELL	$17.54 - $25.22 $1.06 Million - $1.52 Million	-60,174 Reduced 46.69%	68,707 $6.48 Million
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $677,004 - $961,076	51,838 Added 67.28%	128,881 $9.53 Million
Q4 2017 Feb 14, 2018	SELL	$11.12 - $15.38 $121,285 - $167,749	-10,907 Reduced 12.4%	77,043 $4.4 Million
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $540,077 - $902,347	47,542 Added 117.65%	87,950 $4.31 Million
Q2 2017 Aug 14, 2017	BUY	N/A	40,408	40,408 $2.96 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Dexcom Inc Transaction History